- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
Patent holdings for IPC class C12N 9/24
Total number of patents in this class: 2976
10-year publication summary
|
233
|
259
|
269
|
246
|
274
|
235
|
230
|
217
|
198
|
77
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novozymes A/S | 3314 |
298 |
| DSM IP Assets B.V. | 5856 |
77 |
| Novozymes, Inc. | 317 |
67 |
| Danisco US Inc. | 1045 |
63 |
| The Regents of the University of California | 18943 |
38 |
| IFP Energies Nouvelles | 2717 |
31 |
| BASF SE | 19740 |
28 |
| Modernatx, Inc. | 1181 |
28 |
| The Trustees of the University of Pennsylvania | 4122 |
26 |
| Universiteit Gent | 1276 |
26 |
| Vib VZW | 799 |
26 |
| Takeda Pharmaceutical Company Limited | 2961 |
22 |
| Codexis, Inc. | 776 |
22 |
| Ansun Biopharma, Inc. | 56 |
21 |
| Lallemand Hungary Liquidity Management LLC | 111 |
21 |
| International N&h Denmark ApS | 205 |
21 |
| The Procter & Gamble Company | 22178 |
18 |
| CJ Cheiljedang Corporation | 2964 |
18 |
| JCR Pharmaceuticals Co., Ltd. | 206 |
18 |
| Palleon Pharmaceuticals Inc. | 39 |
18 |
| Other owners | 2089 |